Protein-Losing Enteropathy Classification and Management

Primary Classification

Inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, cause mucosal damage leading to protein loss, according to Praxis Medical Insights 1
Gastrointestinal infections, including bacterial, viral, and parasitic infections, can damage the intestinal mucosa, leading to protein loss, as reported by Praxis Medical Insights 1
Primary intestinal lymphangiectasia, also known as Waldmann's disease, is characterized by dilated intestinal lymphatics, as described by Praxis Medical Insights 1
Eosinophilic gastroenteritis is an inflammatory condition without visible erosions, leading to protein loss, according to Praxis Medical Insights 1
Medication-induced enteropathy, caused by medications such as olmesartan, mycophenolate mofetil, and azathioprine, can lead to protein loss, as reported by Praxis Medical Insights 1
Cardiac causes, including Fontan circulation and constrictive pericarditis, can increase central venous pressure, leading to protein loss, according to Praxis Medical Insights 1

Myopathies, involving smooth muscle cells, can cause intestinal dysmotility and protein loss, with primary myopathies often being familial or genetic, and secondary myopathies being more common in adults, as described by Gut 2
Neuropathies, involving enteric neurons, are more common than myopathies in causing small bowel dysmotility, leading to protein loss, according to Gut 2 and 3
Mesenchymopathies, involving interstitial cells of Cajal, can cause intestinal dysmotility and protein loss, characterized by decreased ICC density and damaged intracellular structures, as reported by Gut 2 and 3

Mild intestinal failure can be managed with oral or dietary adjustments and/or oral salt and water supplementation, as recommended by Clinical Nutrition 4 and 5
Moderate intestinal failure requires enteral nutrients and/or salt and water supplementation, according to Clinical Nutrition 4
Severe intestinal failure necessitates parenteral nutrients and/or saline administration, as reported by Clinical Nutrition 4 and 5

Acute protein-losing enteropathy can be hyperacute (type 1) or subacute (type 2), often related to perioperative or chemotherapy-related complications, or abdominal surgery with enterocutaneous fistulas, as described by Clinical Nutrition 4
Chronic protein-losing enteropathy (type 3) is a long-term situation requiring ongoing nutritional and/or electrolyte therapy, according to Clinical Nutrition 4 and 5

Some conditions, such as systemic sclerosis, vasculitis, and amyloidosis, may present with both myopathic and neuropathic features, leading to protein loss, as reported by Gut 2
The diagnosis of protein-losing enteropathy can be challenging, with radiological, isotopic, manometric, and histological findings not always aligning, according to Gut 2 and 3
Treatment for cardiac causes of protein-losing enteropathy may include heart transplantation, atrial septal fenestration, or pericardiectomy, as recommended by Praxis Medical Insights 1
Regular monitoring of serum albumin levels is necessary to evaluate treatment efficacy, according to Praxis Medical Insights 1